(VIANEWS) - Merchants Bancorp (MBINP), Blackrock Health Sciences Trust (BME), Gabelli Global Small and Mid Cap Value Trust (GGZ) are the highest dividend yield stocks on this list.
| Rank | Financial Asset | Price | Change | Forward Dividend Yield | Updated (EST) |
|---|---|---|---|---|---|
| 1 | Merchants Bancorp (MBINP) | 26.60 | -1.23% | 6.22% | 2022-02-18 16:43:14 |
| 2 | Blackrock Health Sciences Trust (BME) | 42.31 | -1.63% | 6.04% | 2022-02-21 11:10:06 |
| 3 | Gabelli Global Small and Mid Cap Value Trust (GGZ) | 13.95 | -2.24% | 3.99% | 2022-02-22 22:41:17 |
| 4 | Gilead Sciences (GILD) | 61.12 | 0.84% | 3.96% | 2022-02-25 16:11:40 |
| 5 | Caesarstone Ltd. (CSTE) | 11.61 | -2.93% | 3.9% | 2022-02-10 22:43:13 |
| 6 | Citigroup (C) | 61.98 | 2.16% | 2.9% | 2022-02-25 16:39:55 |
| 7 | Great Southern Bancorp (GSBC) | 60.52 | 0.62% | 2.42% | 2022-02-12 00:09:52 |
| 8 | Allstate (ALL) | 124.17 | 3.5% | 2.37% | 2022-02-25 16:38:27 |
A little less 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Merchants Bancorp (MBINP) - Dividend Yield: 6.22%
Merchants Bancorp operates as the diversified bank holding company in the United States. The company operates through Multi-family Mortgage Banking, Mortgage Warehousing, and Banking segments. The Multi-family Mortgage Banking segment originates and services government sponsored mortgages for multi-family and healthcare facilities. The Mortgage Warehousing segment funds agency eligible residential loans, including origination, purchase, and sale in the secondary market, as well as commercial loans to non-depository financial institutions. The Banking segment offers a range of financial products and services to consumers and businesses, such as various types of deposit products comprising checking, savings, money market, certificates of deposit, and time deposit accounts; and multi-family construction and bridge, commercial real estate, commercial and industrial, residential mortgage, and consumer loan products. This segment also engages in the agricultural lending, small business administration lending, single-family mortgage lending, and correspondent lending and servicing businesses. It operates 16 branches in various states, including Indiana, Illinois, Florida, New York, and Minnesota. Merchants Bancorp was founded in 1990 and is headquartered in Carmel, Indiana.
Volume
Today's last reported volume for Merchants Bancorp is 1290, 5.13% above its average volume of 1227.
Merchants Bancorp's last close was $26.93, 10.95% under its 52-week high of $30.24.
Merchants Bancorp's Revenue
Year-on-year quarterly revenue growth grew by 7%, now sitting on 427.74M for the twelve trailing months.
Merchants Bancorp's Stock Yearly Top and Bottom Value
Merchants Bancorp's stock is valued at $26.60 at 16:15 EST, way below its 52-week high of $30.24 and above its 52-week low of $25.39.
Merchants Bancorp's Moving Average
Merchants Bancorp's value is below its 50-day moving average of $27.47 and under its 200-day moving average of $27.44.More news about Merchants Bancorp.
2. Blackrock Health Sciences Trust (BME) - Dividend Yield: 6.04%
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
Volume
Today's last reported volume for Blackrock Health Sciences Trust is 54471, 58.59% above its average volume of 34346.
Blackrock Health Sciences Trust's last close was $42.31, 15.35% under its 52-week high of $49.98.
Blackrock Health Sciences Trust's Revenue
Year-on-year quarterly revenue growth grew by 17.4%, now sitting on 5.72M for the twelve trailing months.
Blackrock Health Sciences Trust's Stock Yearly Top and Bottom Value
Blackrock Health Sciences Trust's stock is valued at $42.31 at 16:15 EST, way below its 52-week high of $49.98 and higher than its 52-week low of $42.09.
Blackrock Health Sciences Trust's Moving Average
Blackrock Health Sciences Trust's value is under its 50-day moving average of $46.04 and way below its 200-day moving average of $47.48.More news about Blackrock Health Sciences Trust.
3. Gabelli Global Small and Mid Cap Value Trust (GGZ) - Dividend Yield: 3.99%
The Gabelli Global Small and Mid Cap Value Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies that are operating across diversified sectors. It primarily invests in value stocks of small and mid-cap companies with a market capitalization of $12 billion or less. The fund benchmarks the performance of its portfolio against the MSCI World SMID Cap Index. The Gabelli Global Small and Mid Cap Value Trust was formed on August 19, 2013 and is domiciled in the United States.
Volume
Today's last reported volume for Gabelli Global Small and Mid Cap Value Trust is 8036, 45.94% below its average volume of 14866.
Gabelli Global Small and Mid Cap Value Trust's last close was $13.95, 19.32% under its 52-week high of $17.29.
Gabelli Global Small and Mid Cap Value Trust's Stock Yearly Top and Bottom Value
Gabelli Global Small and Mid Cap Value Trust's stock is valued at $13.95 at 16:15 EST, way under its 52-week high of $17.29 and higher than its 52-week low of $13.74.
Gabelli Global Small and Mid Cap Value Trust's Moving Average
Gabelli Global Small and Mid Cap Value Trust's value is under its 50-day moving average of $15.19 and way under its 200-day moving average of $15.80.More news about Gabelli Global Small and Mid Cap Value Trust.
4. Gilead Sciences (GILD) - Dividend Yield: 3.96%
Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company's products include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, and Truvada for the treatment of human immunodeficiency virus (HIV) infection; and Vosevi, Vemlidy, Epclusa, Harvoni, and Viread products for treating liver diseases. It also provides Yescarta, a chimeric antigen receptor T cell therapy for adult patients with relapsed or refractory large B-cell lymphoma; Zydelig, a kinase inhibitor; Letairis, an oral formulation of an endothelin receptor antagonist for pulmonary arterial hypertension; Ranexa, a tablet to treat chronic angina; and AmBisome, an antifungal agent to treat serious invasive fungal infections. In addition, the company offers its products under the name Cayston, Emtriva, Hepsera, Sovaldi, and Tybost. Further, it develops product candidates for the treatment of viral diseases, inflammatory and fibrotic diseases, and oncology. The company markets its products through its commercial teams; and in conjunction with third-party distributors and corporate partners. Gilead Sciences, Inc. has collaboration agreements with Bristol-Myers Squibb Company; Janssen Sciences Ireland UC; Japan Tobacco Inc.; Galapagos NV; Second Genome; Gadeta; Carna Biosciences Inc.; Nurix Therapeutics, Inc.; Humanigen, Inc.; Kiniksa Pharmaceuticals, Ltd.; Kyverna Therapeutics, Inc.; Glympse Bio, Inc.; Renown Institute for Health Innovation; Goldfinch Bio, Inc.; Insitro, Inc.; Novo Nordisk A/S; Yuhan Corporation; Kite Pharma, Inc.; oNKo-innate Pty. Ltd.; and Roche Holding AG. The company has partnership with Arcus Biosciences, Inc. to co-develop and co-commercialize next-generation cancer immunotherapies. Gilead Sciences, Inc. was founded in 1987 and is headquartered in Foster City, California.
Volume
Today's last reported volume for Gilead Sciences is 12919200, 35.78% above its average volume of 9514980.
Gilead Sciences's last close was $61.12, 16.66% below its 52-week high of $73.34.
Gilead Sciences's Sales
Gilead Sciences's sales growth is a negative 6.4% for the ongoing quarter and a decline by 15.6% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 20.9% and a negative 31.5%, respectively.
Gilead Sciences's Revenue
Year-on-year quarterly revenue growth grew by 20.9%, now sitting on 26.64B for the twelve trailing months.
Gilead Sciences's Stock Yearly Top and Bottom Value
Gilead Sciences's stock is valued at $61.12 at 16:15 EST, way under its 52-week high of $73.34 and above its 52-week low of $56.56.
Gilead Sciences's Moving Average
Gilead Sciences's value is way under its 50-day moving average of $67.96 and way below its 200-day moving average of $68.00.More news about Gilead Sciences.
5. Caesarstone Ltd. (CSTE) - Dividend Yield: 3.9%
Caesarstone Ltd., together with its subsidiaries, develops, manufactures, and markets engineered quartz surfaces under the Caesarstone brand in the United States, Australia, Canada, Latin America, Asia, Israel, Europe, the Middle East, and Africa. The company's engineered quartz slabs are primarily used as kitchen countertops in the renovation and remodeling construction end markets, as well as in new buildings construction market. Its products are also used in other applications, such as vanity tops, wall panels, back splashes, floor tiles, stairs, furniture, and other interior and exterior surfaces that are used in various residential and non-residential applications. The company also offers porcelain products under the Lioli brand for flooring and cladding applications, as well as resells natural stones, and fabrication and installation accessories. It sells its products directly to fabricators, sub-distributors, and resellers; and indirectly through a network of independent distributors. The company was formerly known as Caesarstone Sdot Yam Ltd. and changed its name to Caesarstone Ltd. in June 2016. Caesarstone Ltd. was founded in 1987 and is headquartered in MP Menashe, Israel.
Volume
Today's last reported volume for Caesarstone Ltd. is 154826, 32.1% above its average volume of 117200.
Caesarstone Ltd.'s last close was $11.61, 41.36% under its 52-week high of $19.80.
Caesarstone Ltd.'s Sales
Caesarstone Ltd.'s sales growth is 15.6% for the current quarter and 19.2% for the next. The company's growth estimates for the current quarter is 20% and a drop 50% for the next.
Caesarstone Ltd.'s Revenue
Year-on-year quarterly revenue growth grew by 31.8%, now sitting on 609.73M for the twelve trailing months.
Caesarstone Ltd.'s Stock Yearly Top and Bottom Value
Caesarstone Ltd.'s stock is valued at $11.61 at 16:15 EST, way below its 52-week high of $19.80 and way higher than its 52-week low of $10.20.
Caesarstone Ltd.'s Moving Average
Caesarstone Ltd.'s worth is below its 50-day moving average of $11.72 and way below its 200-day moving average of $13.30.More news about Caesarstone Ltd..
6. Citigroup (C) - Dividend Yield: 2.9%
Citigroup Inc., a diversified financial services holding company, provides various financial products and services to consumers, corporations, governments, and institutions in North America, Latin America, Asia, Europe, the Middle East, and Africa. The company operates in two segments, Global Consumer Banking (GCB) and Institutional Clients Group (ICG). The GCB segment offers traditional banking services to retail customers through retail banking, Citi-branded cards, and Citi retail services. It also provides various banking, credit card lending, and investment services through a network of local branches, offices, and electronic delivery systems. The ICG segment offers wholesale banking products and services, including fixed income and equity sales and trading, foreign exchange, prime brokerage, derivative services, equity and fixed income research, corporate lending, investment banking and advisory services, private banking, cash management, trade finance, and securities services to corporate, institutional, public sector, and high-net-worth clients. As of December 31, 2019, it operated 2,348 branches primarily in the United States, Mexico, and Asia. Citigroup Inc. was founded in 1812 and is headquartered in New York, New York.
Volume
Today's last reported volume for Citigroup is 29690100, 19.19% above its average volume of 24910400.
Citigroup's last close was $61.98, 22.8% below its 52-week high of $80.29.
Citigroup's Sales
Citigroup's sales growth is a negative 0.8% for the ongoing quarter and 2.5% for the next. The company's growth estimates for the current quarter is 28.6% and a drop 19.2% for the next.
Citigroup's Revenue
Year-on-year quarterly revenue growth grew by 58.3%, now sitting on 71.69B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Citigroup's stock is considered to be overbought (>=80).
Citigroup's Stock Yearly Top and Bottom Value
Citigroup's stock is valued at $61.98 at 16:15 EST, way under its 52-week high of $80.29 and way higher than its 52-week low of $47.71.
Citigroup's Moving Average
Citigroup's worth is way below its 50-day moving average of $70.50 and way below its 200-day moving average of $71.61.More news about Citigroup.
7. Great Southern Bancorp (GSBC) - Dividend Yield: 2.42%
Great Southern Bancorp, Inc. operates as a bank holding company for Great Southern Bank that offers a range of financial services in the United States. Its deposit products include regular savings accounts, checking accounts, money market accounts, fixed interest rate certificates with varying maturities, certificates of deposit, brokered certificates, and individual retirement accounts. The company's loan portfolio comprises residential and commercial real estate loans, construction loans, commercial business loans, home improvement loans, and unsecured consumer loans, as well as secured consumer loans, including automobile loans, boat loans, home equity loans, loans secured by savings deposits. It also provides insurance and merchant banking services. As of December 31, 2020, the company operated 94 retail banking centers and approximately 200 automated teller machines in Missouri, Iowa, Minnesota, Kansas, Nebraska, and Arkansas; and six commercial and one mortgage loan production offices in Atlanta, Chicago, Dallas, and Omaha, Nebraska, as well as Tulsa, Okla, and Springfield, Missouri. Great Southern Bancorp, Inc. was founded in 1923 and is headquartered in Springfield, Missouri.
Volume
Today's last reported volume for Great Southern Bancorp is 33238, 17.56% below its average volume of 40318.
Great Southern Bancorp's last close was $60.52, 2.31% below its 52-week high of $61.95.
Great Southern Bancorp's Sales
Great Southern Bancorp's sales growth is a negative 1.8% for the ongoing quarter and a decline by 3.7% for the next. The company's growth estimates for the present quarter and the next is a negative 0.8% and a negative 16.9%, respectively.
Great Southern Bancorp's Revenue
Year-on-year quarterly revenue growth grew by 16.2%, now sitting on 219.81M for the twelve trailing months.
Great Southern Bancorp's Stock Yearly Top and Bottom Value
Great Southern Bancorp's stock is valued at $60.52 at 16:15 EST, under its 52-week high of $61.95 and way higher than its 52-week low of $49.53.
Great Southern Bancorp's Moving Average
Great Southern Bancorp's value is above its 50-day moving average of $58.96 and higher than its 200-day moving average of $55.98.More news about Great Southern Bancorp.
8. Allstate (ALL) - Dividend Yield: 2.37%
The Allstate Corporation, through its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. The company operates through Allstate Protection, Service Businesses, Allstate Life, and Allstate Benefits segments. The Allstate Protection segment offers private passenger auto and homeowners insurance; specialty auto products, including motorcycle, trailer, motor home, and off-road vehicle insurance; other personal lines products, such as renter, condominium, landlord, boat, umbrella, and manufactured home and stand-alone scheduled personal property; liability insurance products; and commercial lines products under the Allstate, Esurance, and Encompass brand names. The Service Businesses segment provides consumer product protection plans; finance and insurance products, including vehicle service contracts, guaranteed asset protection waivers, road hazard tire and wheel, and paint less dent repair protection; roadside assistance; device and mobile data collection services; and analytic solutions using automotive telematics information and identity protection. This segment offers its products under various brands including Allstate Protection Plans, Allstate Dealer Services, Allstate Roadside Services, Arity, and Allstate Identity Protection. The Allstate Life Segment offers traditional, interest-sensitive, and variable life insurance products, as well as non-proprietary retirement product solutions offered by third-party providers. Its Allstate Benefits segment provides life, accident, critical illness, short-term disability, and other health insurance products. The company sells its products through direct contact centers, agencies, financial specialists, brokers, wholesale partners, and affinity groups, as well as through online and mobile applications. The Allstate Corporation was founded in 1931 and is based in Northbrook, Illinois.
Volume
Today's last reported volume for Allstate is 1756860, 29.84% below its average volume of 2504190.
Allstate's last close was $124.17, 11.31% below its 52-week high of $140.00.
Allstate's Sales
Allstate's sales growth is 12.8% for the ongoing quarter and a decline by 18.8% for the next. The company's growth estimates for the current quarter and the next is a negative 11.9% and a negative 40.7%, respectively.
Allstate's Revenue
Year-on-year quarterly revenue growth grew by 21.6%, now sitting on 49.62B for the twelve trailing months.
Allstate's Stock Yearly Top and Bottom Value
Allstate's stock is valued at $124.17 at 16:15 EST, way under its 52-week high of $140.00 and way higher than its 52-week low of $93.95.
Allstate's Moving Average
Allstate's value is under its 50-day moving average of $125.78 and below its 200-day moving average of $130.68.More news about Allstate.